Elenco degli articoli con argomento «psoriasi»
Dermatologia11 set 2018
Topical Janus kinase inhibitors: A review of applications in dermatology
J Am Acad Dermatol. 2018 Sep;79(3):535-544.
04 set 2018
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study
04 set 2018
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis
Dietary Recommendations for Adults With Psoriasis or Psoriatic Arthritis From the Medical Board of the National Psoriasis FoundationA Systematic Review
25 lug 2018
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation
Expert Opin Biol Ther. 2018 Jul;18(7):727-735. doi: 10.1080/14712598.2018.1481503. Epub 2018 Jun 6.
29 mag 2018
Switching from a biological therapy to another biologic agent in psoriatic patients: the experience of PsOMarche group
Switching is a "hot" topic and the main reasons for switching prior biologic agent are for a primary failure, a secondary failure or drug intolerance, patient's dissatisfaction, physician decision. The aim of the study was to assess the optimization of the switching from a biologic agent to another
15 mag 2018
Buoni risultati per secukinumab contro la psoriasi del cuoio capelluto
L'inibitore dell'interleuchina-17A (IL-17A) secukinumab migliora in maniera significativa la clearance cutanea nei pazienti affetti da psoriasi del cuoio capelluto
07 mag 2018
Cumulative exposure to biologics and risk of cancer in psoriasis patients: A meta-analysis of Psonet studies from Israel, Italy, Spain, UK
Objectives: to assess a dose-response relationship between cumulative length of exposure to biologic therapy and risk of cancer.
29 apr 2018
Corriere.it, la nuova campagna "Chiedi al dermatologo"
La nuova campagna "Chiedi al tuo dermatologo" sul Corriere.it
10 apr 2018
Serum levels of tumor necrosis factor-alpha in patients with psoriasis before, during and after narrow-band UVB phototherapy
We investigate serum levels of tumor necrosis factor-? (TNF-?) in psoriatic patients before and after NB-UVB phototherapy
06 apr 2018
Childhood trauma and resilience in psoriatic patients: A preliminary report
The aim of the study was to investigate childhood trauma and resilience in a psoriatic sample compared with healthy controls. Correlations between childhood trauma, resilience, quality of life, clinical data and psoriatic features were also evaluated
02 apr 2018
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the BADBIR
Serious infection is a concern for patients with psoriasis receiving biologic therapies. We assessed the risk of serious infections for biologics used to treat psoriasis by comparison with a cohort receiving non-biologic systemic therapies in a propensity score-weighted Cox proportional hazards model using data from the BADBIR
20 gen 2018
Association of Psoriasis With Comorbidity Development in Children With Psoriasis
Objective: determine the risk of elevated lipid levels (hyperlipidemia/hypertriglyceridemia), hypertension, metabolic syndrome, polycystic ovarian syndrome, diabetes, nonalcoholic liver disease, and elevated liver enzyme levels in children with and without psoriasis, after accounting for obesity
18 dic 2017
Bambini con psoriasi: farmaci efficaci e con una tossicità accettabile
Quando la malattia è in forma moderata o grave serve una terapia con medicinali. Un'indagine internazionale fa il punto sugli effetti collaterali nei pazienti più piccoli
11 dic 2017
Psoriasi, più rischi per chi ha gran parte della pelle coperta da chiazze
Uno studio Usa sostiene che quanto maggiore è la superficie cutanea interessata, tanto più alto è il pericolo di morire a causa della malattia o di altre patologie collegate
11 dic 2017
Psoriasi a placche, un nuovo farmaco funziona nei malati più gravi
Compare di solito tra i 20 e i 30 anni ed è la forma più comune di questa malattia. Due studi hanno dimostrato l’efficacia di un medicinale biologico, che ha «pulito» la pelle
30 nov 2017
Psoriasis Severity Linked to Increased Risk of Type 2 Diabetes
People with psoriasis have a higher risk of developing type 2 diabetes than those without psoriasis, and the risk increases dramatically based on the severity of the disease, according to a study published in the Journal of the American Academy of Dermatology
30 nov 2017
No Increase in Thromboembolic Events With Tofacitinib Treatment for Multiple Conditions
Investigators have found no evidence of an increased risk of venous thromboembolic events (VTE) in patients treated with tofacitinib for rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), or ulcerative colitis (UC)
13 nov 2017
Microbiota e psoriasi: che relazione c'è?
Nelle malattie infiammatorie della cute come la psoriasi o la dermatite atopica il microbiota subisce delle variazioni significative soprattutto nel senso della perdita della normale diversità con lo sviluppo di una preponderanza di alcune specie sulle altre
13 nov 2017
Secukinumab Reduces Anxiety, Depression in Patients With Psoriatic Arthritis
The higher anxiety and depression burden typically seen in patients with psoriatic arthritis and psoriasis is improved with secukinumab treatment
08 nov 2017
I farmaci biologici sono efficaci contro la psoriasi anche per anni
Un'indagine svedese ha seguito i pazienti per anni, analizzando l'efficacia dei medicinali e la qualità di vita delle persone. Le conclusioni: Funzionano e sono ben tollerati